MTU951Tissue Micro Arrays

MTU951

40 types of tumors covering all the common benign, malignant and metastatic entities originated from 27 anatomic sites. Most of them have duplicates or triplicates from different individuals with corresponding uninvolved tissues as controls with grading and TNM staging data.

Specifications

Price per slide:

$289

Species:

Human

Cases:

95 Cores:

95 Core Size:

1.5mm

Core Thickness:

4um

Rows:

8 Columns:

12 Format:

Learn More

Intended Usage:

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in all the common types of benign and malignant tumors.

8 X

12

For illustration purpose only. Actual product may vary.

Notes:

All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.

Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.

Download Data sheet

Download MSDS

ARRAY POSITION	SEX	AGE	ANATOMIC SITE	PATHOLOGY	NATURE	GRADE	STAGE (TNM)
A01	F	37	Adrenal gland	Normal, hyperplasia	Normal
A02	M	35	Adrenal gland	Adenoma, cortical	Benign
A03	M	28	Adrenal gland	Adrenocortical carcinoma	Malignant		T2N0M0
A04	M	53	Bladder, urinary	Normal	Normal
A05	F	53	Bladder, urinary	Transitional cell carcinoma	Malignant	I~II	T1N0M0
A06	F	65	Bladder, urinary	Transitional cell carcinoma	Malignant	I~II	T1N0M0
A07	F	30	Breast	Normal	Normal
A08	F	40	Breast	Fibroadenoma	Benign
A09	F	39	Breast	Fibroadenoma	Benign
A10	F	58	Breast	Invasive ductal carcinoma	Malignant	II	T2N1M0
A11	F	53	Breast	Invasive ductal carcinoma	Malignant	II	T2N0M0
A12	F	42	Breast	Invasive ductal carcinoma	Malignant	II	T4N1M0
B01	M	17	Bone, tibia	Osteosarcoma	Malignant
B02	M	44	Bone, scapula	Chondrosarcoma	Malignant
B03	M	58	Brain, cerebellum*	Normal, cerebellum*	Normal
B04	F	65	Brain, cerebellum	Meningioma, fibroblastic	Benign
B05	M	55	Brain, cerebellum	Malignant meningioma	Malignant
B06	M	58	Brain, cerebral cortex*	Normal cerebral cortex*	Normal
B07	F	26	Brain	Meningioma, fibroblastic	Benign
B08	M	47	Brain	Astrocytoma	Benign	II
B09	M	53	Esophagus	Normal	Normal
B10	F	68	Esophagus	Squamous cell carcinoma	Malignant	I	T2N0M0
B11	M	54	Esophagus	Squamous cell carcinoma	Malignant	II	T3N1M0
B12	F	61	Esophagus	Squamous cell carcinoma	Malignant	III	T2N1M0
C01	M	59	Stomach	Normal	Normal
C02	M	52	Stomach	Adenocarcinoma	Malignant	I	T2N0M0
C03	M	66	Stomach	Adenocarcinoma	Malignant	II	T3N0M0
C04	M	47	Stomach	Adenocarcinoma	Malignant	III	T3N2M0
C05	F	40	Intestine, small intestine	Normal	Normal
C06	F	18	Intestine, small intestine	Adenoma	Benign
C07	F	57	Intestine, small intestine	Adenocarcinoma	Malignant	II	T2N0M0
C08	F	27	Intestine, colon	Normal	Normal
C09	M	57	Intestine, colon	Adenoma	Benign
C10	M	56	Intestine, colon	Adenocarcinoma	Malignant	I	T3N0M0
C11	M	89	Intestine, colon	Adenocarcinoma	Malignant	II	T2N0M0
C12	F	43	Intestine, colon	Adenocarcinoma	Malignant	III	T3N0M0
D01	M	61	Intestine, rectum	Normal	Normal
D02	M	40	Intestine, rectum	Adenocarcinoma	Malignant	I	T3N0M0
D03	M	38	Intestine, rectum	Adenocarcinoma	Malignant	II	T3N1M0
D04	M	50	Intestine, rectum	Adenocarcinoma	Malignant	III	T3N1M0
D05	F	51	Kidney	Normal cortex	Normal
D06	M	40	Kidney	Clear cell carcinoma	Malignant		T1N0M0
D07	F	79	Kidney	Clear cell carcinoma	Malignant		T1N0M0
D08	M	43	Liver	Normal	Normal
D09	M	26	Liver	Hepatocellular carcinoma	Malignant	I	T2N0M0
D10	M	40	Liver	Hepatocellular carcinoma	Malignant	II	T2N0M0
D11	M	53	Liver	Hepatocellular carcinoma	Malignant	I	T2N0M0
D12	M	41	Liver	Hepatocellular carcinoma	Malignant	III	T2N0M0
E01	M	58	Lung	Normal	Normal
E02	M	59	Lung	Squamous cell carcinoma	Malignant	II	T2N2M0
E03	M	62	Lung	Squamous cell carcinoma	Malignant	II~III	T2N0M0
E04	M	72	Lung	Adenocarcinoma	Malignant	III	T2N2M0
E05	M	19	Lung	Small cell carcinoma	Malignant		T3N0M0
E06	F	39	Lymph node	Reactive	Inflammatory
E07	M	50	Lymph node, neck	Lymphoma, Hodgkin lymphoma	Malignant
E08	M	42	Lymph node, axillary	Lymphoma, non-Hodgkin B-cell lymphoma	Malignant
E09	M	51	Lymph node, neck	Lymphoma, anaplastic large cell lymphoma	Malignant
E10	F	48	Head and neck, oral cavity, hard palate	Adenocarcinoma	Malignant	III~IV
E11	M	56	Head and neck, oral cavity, tongue	Squamous cell carcinoma	Malignant	II	T2N0M0
E12	F	48	Head and neck, nasopharynx	Nasopharyngeal carcinoma, NPC	Malignant	III	T2N0M0
F01	F	45	Ovary	Normal	Normal
F02	F	55	Ovary	Granulosa cell tumor	Benign
F03	F	45	Ovary	Adenocarcinoma	Malignant	III	T2N0M0
F04	F	49	Ovary	Endometrioid adenocarcinoma	Malignant	III	T1N0M0
F05	M	35	Pancreas	Normal	Normal
F06	F	49	Pancreas	Adenocarcinoma	Malignant	II	T3N1M1
F07	M	65	Prostate	Normal, hyperplasia	Normal
F08	M	60	Prostate	Adenocarcinoma	Malignant	II	T2N0M0
F09	M	63	Prostate	Adenocarcinoma	Malignant	III	T3N0M0
F10	M	38	Head and neck, salivary gland	Normal	Normal
F11	F	28	Head and neck, salivary gland, parotid	Pleomorphic adenoma	Benign
F12	F	38	Head and neck, salivary gland	Adenoid cystic carcinoma	Malignant	I~II	T1N0M0
G01	M	50	Skin	Normal	Normal
G02	M	67	Skin, trunk	Squamous cell carcinoma	Malignant	II	T2N0M0
G03	M	53	Head and neck, nasal cavity	Melanoma	Malignant
G04	M	77	Testis	Normal	Normal
G05	M	30	Testis	Seminoma	Malignant
G06	M	28	Testis	Seminoma	Malignant
G07	F	62	Thyroid	Normal	Normal
G08	F	47	Thyroid	Adenoma	Benign
G09	F	27	Thyroid	Adenoma	Benign
G10	F	66	Thyroid	Adenoma	Benign
G11	M	16	Thyroid	Follicular carcinoma	Malignant		T3N1M0
G12	M	34	Thyroid	Follicular papillary adenocarcinoma	Malignant		T2N1M0
H01	F	41	Uterus, cervix	Normal	Normal
H02	F	63	Uterus, cervix	Squamous cell carcinoma	Malignant	III	T1N0M0
H03	F	57	Uterus, cervix	Squamous cell carcinoma	Malignant	III	T1N1M0
H04	F	50	Uterus, endometrium	Normal	Normal
H05	F	48	Uterus, endometrium	Adenocarcinoma	Malignant	I~II	T2N0M0
H06	F	53	Uterus, endometrium	Adenocarcinoma	Malignant	II~III	T1N1M0
H07	M	60	Liver	Metastatic colon adenocarcinoma	Metastasis
H08	M	69	Lung	Metastatic cancers, from gastrointestional site?	Metastasis
H09	F	34	Lymph node	Metastatic breast invasive ductal carcinoma	Metastasis
H10	F	40	Ovary	Metastatic colon signet ring cell carcinoma	Metastasis
H11	M	51	Lymph node	Metastatic esophagus squamous cell carcinoma	Metastasis

GENERAL INFORMATION

CONTROL TMA

ANIMALS

NATURE

BY LETTER

ANATOMIC SYSTEM

ANATOMIC SITE

SERVICES

CUSTOM TMA

IMAGING / PATHOLOGY ANALYSIS

ROUTINE PATHOLOGY

IHC / IMMUNOFLUORESCENCE

ISH / FISH

CONTRACTED SERVICES

PRIMARY IHC ANTIBODIES

PATHOLOGY FIELD

Hermatopathology

DETECTION SYSTEMS

ANCILLARIES

CONTROL TMA

SPECIES

GENERAL INFORMATION

BY LETTER

NATURE

ANATOMIC SYSTEM

ANATOMIC SITE

GENERAL INFORMATION

BY LETTER

NATURE

ANATOMIC SYSTEM

ANATOMIC SITE

MTU951

40 types of tumors covering all the common benign, malignant and metastatic entities originated from 27 anatomic sites. Most of them have duplicates or triplicates from different individuals with corresponding uninvolved tissues as controls with grading and TNM staging data.

Price per slide:

$289

Species:

Human

Cases:

95

Cores:

95

Core Size:

1.5mm

Core Thickness:

4um

Rows:

8

Columns:

12

Format:

Intended Usage:

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in all the common types of benign and malignant tumors.

8

X

12

For illustration purpose only. Actual product may vary.

Notes:

​

Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.

Download Data sheet

Download MSDS

1049 Union Ave. Suite D

Fairfield, CA 94533

Tel: (415) 863-2380

Fax: (510) 225-1084

E-mail:

HELPFUL LINKS

​

ABOUT US

CONTACT US

​

LEGAL​

​

© 2021 Pantomics Inc.

LEGAL